title: Questioning patient subgroups for benefit assessment: challenging the German Gemeinsamer Bundesausschuss approach.
authors: Roche Pharma AG, Grenzach-Wyhlen, Germany; Hannover Medical School, Hannover, Germany. Electronic address: joerg.ruof@roche.com.
authors: Jörg
authors: J
authors: Ruof
authors: German Association of Research-based Pharmaceutical Companies (vfa), Berlin, Germany; Department of Public Health, Heinrich Heine University, Düsseldorf, Germany.
authors: Charalabos-Markos
authors: CM
authors: Dintsios
authors: Hannover Medical School, Hannover, Germany.
authors: Friedrich Wilhelm
authors: FW
authors: Schwartz
mesh_terms: D003363:Cost Control; D019317:Evidence-Based Medicine; D005858:Germany; D017048:Health Care Costs; D018166:Health Care Reform / Q000331:legislation & jurisprudence*; D006801:Humans; D009313:National Health Programs / Q000191:economics* / Q000331:legislation & jurisprudence*; D055553:Prescription Drugs / Q000191:economics* / Q000627:therapeutic use; D012051:Reimbursement Mechanisms
chemical_list: D055553:Prescription Drugs